SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kimia Biosciences informs about statement of investor complaints/grievances

22 Jan 2025 Evaluate
Pursuant to Regulation 13(3) of the SEBI (Listing and Obligation and Disclosures requirements) Regulation2015, Kimia Biosciences has informed that it enclosed the statement of investor complaints/grievances for the quarter ended December 31, 2024.

The above information is a part of company’s filings submitted to BSE.

Kimia Biosciences Share Price

35.73 3.81 (11.94%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×